Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 6, 2004
Reporting Period: Quarter ended March 31, 2004
This filing serves as a current report to announce the issuance of a press release regarding the company's financial results for the quarter ended March 31, 2004. The actual financial data is contained within the attached press release (Exhibit 99.1) and is incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K filing.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the announcement of results for the quarter ended March 31, 2004.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the text of this filing. The document strictly functions as a notification of the press release's existence.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 6, 2004) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the attached press release.
- Check for any forward-looking statements or guidance included in the press release text.
- Confirm the company's liquidity position and debt levels as disclosed in the full press release.